Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 16, 2023; 11(32): 7770-7777
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7770
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7770
Table 3 Comparison of blood gas analysis between the two groups of patients before and after treatment
| Group | PaO2 (mmHg) | PaO2/FiO2 (mmHg) | PaCO2 (mmHg) | SaO2 (%) | ||||
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| Control group (40) | 67.44 ± 7.23 | 93.27 ± 8.14 | 172.34 ± 11.25 | 291.81 ± 7.82 | 52.23 ± 6.57 | 39.67 ± 2.24 | 94.76 ± 3.15 | 96.45 ± 0.15 |
| Therapy group (40) | 67.40 ± 7.22 | 98.37 ± 8.20 | 172.31 ± 11.64 | 322.27 ± 7.81 | 52.24 ± 6.53 | 37.23 ± 2.26 | 94.75 ± 3.26 | 97.57 ± 0.16 |
| t | 0.025 | 2.792 | 0.012 | 17.431 | 0.007 | 4.850 | 0.014 | 32.298 |
| P value | 0.980 | 0.007 | 0.991 | < 0.001 | 0.995 | 0.012 | 0.989 | 0.035 |
- Citation: Chen X, Dai L, Ma JZ, Chu XX, Dai L, Liu JM, Guo SW, Ru XW, Zhuang XS. Clinical study of NFNC in the treatment of acute exacerbation chronic obstructive pulmonary disease patients with respiratory failure. World J Clin Cases 2023; 11(32): 7770-7777
- URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7770.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i32.7770